Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Lin

Showing results (161-170 of 328) with videos related to

Pageof 33
Sort By:
The Annals of Thoracic Surgery|July 24, 2012
The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapyArya Amini, Arlene M Correa, Ritsuko Komaki, et al.
Nature Communications|October 3, 2020
Multi-omics prediction of immune-related adverse events during checkpoint immunotherapyYing Jing, Jin Liu, Youqiong Ye, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2017
The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapyMian Xi, Cai Xu, Zhongxing Liao, et al.
JCO Precision Oncology|December 14, 2022
Monitoring PD-L1 Expression on Circulating Tumor-Associated Cells in Recurrent Metastatic Non-Small-Cell Lung Carcinoma Predicts Response to Immunotherapy With Radiation TherapyJillian A Moran, Daniel L Adams, Martin J Edelman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 30, 2020
Incidence and Onset of Severe Cardiac Events After Radiotherapy for Esophageal CancerXin Wang, Nicolas L Palaskas, Syed Wamique Yusuf, et al.
Clinical and Translational Radiation Oncology|March 29, 2021
Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up studyWang Jing, Yufei Liu, Hui Zhu, et al.
Lung Cancer (Amsterdam, Netherlands)|October 28, 2025
Mutation testing, treatment patterns, and outcomes in patients with unresectable stage III EGFR-mutated non-small cell lung cancer treated with chemoradiotherapy: Final analysis of a global real-world studyMyung-Ju Ahn, Steven H Lin, Cheng-Ta Yang, et al.
Nature Communications|February 5, 2016
PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemnessXin Wang, Youn-Sang Jung, Sohee Jun, et al.
International Journal of Radiation Oncology, Biology, Physics|March 16, 2012
Proton beam therapy and concurrent chemotherapy for esophageal cancerSteven H Lin, Ritsuko Komaki, Zhongxing Liao, et al.
Seminars in Radiation Oncology|August 30, 2021
Biology of the Radio- and Chemo-Responsiveness in HPV MalignanciesMichael T Spiotto, Cullen M Taniguchi, Ann H Klopp, et al.
Pageof 33

Showing results (161-170 of 328) with videos related to

Sort By:
Pageof 33
The Annals of Thoracic Surgery|July 24, 2012
The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapyArya Amini, Arlene M Correa, Ritsuko Komaki, et al.
Nature Communications|October 3, 2020
Multi-omics prediction of immune-related adverse events during checkpoint immunotherapyYing Jing, Jin Liu, Youqiong Ye, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2017
The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapyMian Xi, Cai Xu, Zhongxing Liao, et al.
JCO Precision Oncology|December 14, 2022
Monitoring PD-L1 Expression on Circulating Tumor-Associated Cells in Recurrent Metastatic Non-Small-Cell Lung Carcinoma Predicts Response to Immunotherapy With Radiation TherapyJillian A Moran, Daniel L Adams, Martin J Edelman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 30, 2020
Incidence and Onset of Severe Cardiac Events After Radiotherapy for Esophageal CancerXin Wang, Nicolas L Palaskas, Syed Wamique Yusuf, et al.
Clinical and Translational Radiation Oncology|March 29, 2021
Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up studyWang Jing, Yufei Liu, Hui Zhu, et al.
Lung Cancer (Amsterdam, Netherlands)|October 28, 2025
Mutation testing, treatment patterns, and outcomes in patients with unresectable stage III EGFR-mutated non-small cell lung cancer treated with chemoradiotherapy: Final analysis of a global real-world studyMyung-Ju Ahn, Steven H Lin, Cheng-Ta Yang, et al.
Nature Communications|February 5, 2016
PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemnessXin Wang, Youn-Sang Jung, Sohee Jun, et al.
International Journal of Radiation Oncology, Biology, Physics|March 16, 2012
Proton beam therapy and concurrent chemotherapy for esophageal cancerSteven H Lin, Ritsuko Komaki, Zhongxing Liao, et al.
Seminars in Radiation Oncology|August 30, 2021
Biology of the Radio- and Chemo-Responsiveness in HPV MalignanciesMichael T Spiotto, Cullen M Taniguchi, Ann H Klopp, et al.
Pageof 33